GLP-1 RAs There are currently four GLP-1 RAs available in Ireland: exenatide, liraglutide, dulaglutide and the recently launched semaglutide
Cognitive decline in Parkinson disease
In both evoke and evoke+, participants received once-daily oral semaglutide or with a planned 2-year primary treatment phase and a subsequent 12-month extension
It plays a crucial role in various cellular processes, including many that can have a direct impact on aging
Subgroup analysis Based on the supplemental subgroup analyses, several notable patterns emerged regarding the associations between Tirzepatide and Semaglutide vs traditional anti-obesity medications across different patient characteristics and clinical contexts (Supplementary Data 522)
Stockley, Elizabeth Sapey, Charlotte Summers, Andrew S